AU1723001A - Methods and means for regulation of gene expression - Google Patents

Methods and means for regulation of gene expression

Info

Publication number: AU1723001A
Authority: AU; Australia
Prior art keywords: regulation; methods; gene expression; gene; expression
Prior art date: 1999-11-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU17230/01A

Inventor

Riccardo Cortese

Raffaele De Francesco

Petra Neddermann

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Istituto di Ricerche di Biologia Molecolare P Angeletti SpA

Original Assignee

Istituto di Ricerche di Biologia Molecolare P Angeletti SpA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-17

Filing date

2000-11-17

Publication date

2001-05-30

2000-11-17 Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpA filed Critical Istituto di Ricerche di Biologia Molecolare P Angeletti SpA

2001-05-30 Publication of AU1723001A publication Critical patent/AU1723001A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor

Landscapes

Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AU17230/01A 1999-11-17 2000-11-17 Methods and means for regulation of gene expression Abandoned AU1723001A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9927191		1999-11-17
GBGB9927191.8A GB9927191D0 (en)	1999-11-17	1999-11-17	Methods and means for regulation of gene expression
PCT/IB2000/001828 WO2001036460A2 (en)	1999-11-17	2000-11-17	Methods and means for regulation of gene expression

Publications (1)

Publication Number	Publication Date
AU1723001A true AU1723001A (en)	2001-05-30

Family

ID=10864679

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU17230/01A Abandoned AU1723001A (en)	1999-11-17	2000-11-17	Methods and means for regulation of gene expression

Country Status (5)

Country	Link
EP (1)	EP1232271A2 (en)
AU (1)	AU1723001A (en)
CA (1)	CA2391971A1 (en)
GB (1)	GB9927191D0 (en)
WO (1)	WO2001036460A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20090946A1 (en) *	2009-05-28	2010-11-29	Novartis Ag	EXPRESSION OF RECOMBINANT PROTEINS
US9428845B1 (en)	2010-12-28	2016-08-30	Warp Drive Bio, Inc.	Identifying new therapeutic agents
TW201629069A (en)	2015-01-09	2016-08-16	霍普驅動生物科技股份有限公司	Compounds that participate in cooperative binding and uses thereof
US10533016B2 (en)	2015-01-09	2020-01-14	Revolution Medicines, Inc.	Compounds that participate in cooperative binding and uses thereof
WO2017059207A1 (en)	2015-10-01	2017-04-06	Warp Drive Bio, Inc.	Methods and reagents for analyzing protein-protein interfaces
KR102359972B1 (en) *	2016-04-12	2022-02-10	징코 바이오웍스, 인크.	Compositions and methods for the preparation of compounds
US11479797B2 (en)	2016-10-28	2022-10-25	Ginkgo Bioworks, Inc.	Compositions and methods for the production of compounds
WO2021050789A1 (en)	2019-09-10	2021-03-18	Obsidian Therapeutics, Inc.	Ca2-il15 fusion proteins for tunable regulation
CN114901366A (en)	2019-11-04	2022-08-12	锐新医药公司	RAS inhibitors
TW202132314A (en)	2019-11-04	2021-09-01	美商銳新醫藥公司	Ras inhibitors
US11566007B2 (en)	2019-11-04	2023-01-31	Revolution Medicines, Inc.	Ras inhibitors
KR20230067635A (en)	2020-09-15	2023-05-16	레볼루션 메디슨즈, 인크.	Indole derivatives as RAS inhibitors in the treatment of cancer
JP2024517845A (en)	2021-05-05	2024-04-23	レボリューションメディシンズインコーポレイテッド	RAS Inhibitors for Cancer Treatment
AR127308A1 (en)	2021-10-08	2024-01-10	Revolution Medicines Inc	RAS INHIBITORS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5196318A (en) *	1990-06-26	1993-03-23	The Texas A&M University System	Precisely regulated expression of deleterious genes
GB9311641D0 (en) *	1993-06-01	1993-07-21	Univ Warwick	Process for activating gene expression in bacteria
GB9817704D0 (en) *	1998-08-13	1998-10-07	Zeneca Ltd	Gene switch
DK1190079T3 (en) *	1999-07-01	2006-10-09	Calgene Llc	Regulation of gene expression in eukaryotic cells

1999
- 1999-11-17 GB GBGB9927191.8A patent/GB9927191D0/en not_active Ceased
2000
- 2000-11-17 AU AU17230/01A patent/AU1723001A/en not_active Abandoned
- 2000-11-17 EP EP00979852A patent/EP1232271A2/en not_active Withdrawn
- 2000-11-17 CA CA002391971A patent/CA2391971A1/en not_active Abandoned
- 2000-11-17 WO PCT/IB2000/001828 patent/WO2001036460A2/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2001036460A2 (en)	2001-05-25
WO2001036460A3 (en)	2002-01-03
GB9927191D0 (en)	2000-01-12
EP1232271A2 (en)	2002-08-21
CA2391971A1 (en)	2001-05-25

Publication	Publication Date	Title
AU4563300A (en)	2000-11-21	Regulation of viral gene expression
AU3225897A (en)	1997-12-09	Regulation of gene expression
AU2913701A (en)	2001-07-16	System and method for facilitating selection of benefits
AU1138499A (en)	1999-06-07	System and method for regulation of gene expression
EP1177277A4 (en)	2003-01-22	Compositions and methods for the modification of gene transcription
GB0130301D0 (en)	2002-02-06	Control of gene expression
AU4206200A (en)	2000-10-23	Compounds and methods for stimulating beta-catenin mediated gene expression and differentiation
AU1723001A (en)	2001-05-30	Methods and means for regulation of gene expression
AUPN816196A0 (en)	1996-03-14	Regulation of eukaryotic gene expression
EP1581614A3 (en)	2005-09-22	Nucleotide sequences for gene regulation and methods of use thereof
AU5328600A (en)	2000-12-28	Nucleotide sequences for gene regulation and methods of use thereof
AU3032699A (en)	2000-09-28	Translation regulation system and methods for use thereof
AU7792900A (en)	2001-04-23	Distribution of certifiers
AU2899800A (en)	2000-09-28	Compounds and methods for stimulating gene expression and cellular differentiation
AU6469699A (en)	2000-05-01	Method of regulating gene expression
AU4397797A (en)	1998-10-20	Method of gene introduction
HUP0302908A3 (en)	2004-11-29	Genes and methods for manipulation of growth
AU2001269077A1 (en)	2002-01-02	Methods and means for regulation of gene expression
AU2001251138A1 (en)	2001-10-15	Compositions and methods for tissue specific gene regulation therapy
AU2759400A (en)	2000-08-29	Method for maintenance and selection of episomes
AUPO947997A0 (en)	1997-10-23	Method of regulating gene expression
EP1163340A4 (en)	2002-08-07	Compositions and methods for the modification of gene expression
AU2841500A (en)	2001-08-20	Dehiscence gene and methods for regulating dehiscence
AU3480197A (en)	1998-01-05	Method and compositions for controlling gene expression
AU6533700A (en)	2001-03-05	Methods of gene expression monitoring

Legal Events

Date	Code	Title	Description
2002-07-18	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase